CN102357164B - 一种临床护理烧伤的药物组合物及其制备方法 - Google Patents
一种临床护理烧伤的药物组合物及其制备方法 Download PDFInfo
- Publication number
- CN102357164B CN102357164B CN2011102578366A CN201110257836A CN102357164B CN 102357164 B CN102357164 B CN 102357164B CN 2011102578366 A CN2011102578366 A CN 2011102578366A CN 201110257836 A CN201110257836 A CN 201110257836A CN 102357164 B CN102357164 B CN 102357164B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- burns
- clinical care
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims description 38
- 239000000203 mixture Substances 0.000 title description 8
- 229940079593 drug Drugs 0.000 title description 7
- 238000002360 preparation method Methods 0.000 title description 7
- 239000008194 pharmaceutical composition Substances 0.000 claims description 16
- 238000011282 treatment Methods 0.000 claims description 13
- 241000628997 Flos Species 0.000 claims description 12
- 206010053615 Thermal burn Diseases 0.000 claims description 11
- 241000563984 Ampelopsis Species 0.000 claims description 6
- 241000717739 Boswellia sacra Species 0.000 claims description 6
- 244000293323 Cosmos caudatus Species 0.000 claims description 6
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 6
- 241001057584 Myrrha Species 0.000 claims description 6
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 6
- 241000180649 Panax notoginseng Species 0.000 claims description 6
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 claims description 6
- 239000009286 sanguis draxonis Substances 0.000 claims description 6
- 235000001892 vitamin D2 Nutrition 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 5
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 claims description 4
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 4
- 241000245240 Lonicera Species 0.000 claims description 4
- 241000545442 Radix Species 0.000 claims description 4
- 235000008282 Sanguisorba officinalis Nutrition 0.000 claims description 4
- 241001180876 Saposhnikovia Species 0.000 claims description 4
- 241000207929 Scutellaria Species 0.000 claims description 4
- 244000111489 Gardenia augusta Species 0.000 claims 1
- 244000173853 Sanguisorba officinalis Species 0.000 claims 1
- 230000000694 effects Effects 0.000 description 20
- 239000000843 powder Substances 0.000 description 13
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 206010052428 Wound Diseases 0.000 description 8
- 208000027418 Wounds and injury Diseases 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 230000035876 healing Effects 0.000 description 6
- 210000002429 large intestine Anatomy 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 231100000241 scar Toxicity 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 230000023597 hemostasis Effects 0.000 description 5
- 206010040943 Skin Ulcer Diseases 0.000 description 4
- 238000001804 debridement Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 231100000019 skin ulcer Toxicity 0.000 description 4
- 241000157835 Gardenia Species 0.000 description 3
- 241000581682 Sanguisorba Species 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 239000004863 Frankincense Substances 0.000 description 2
- 229920000153 Povidone-iodine Polymers 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 210000000589 cicatrix Anatomy 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229960001621 povidone-iodine Drugs 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 2
- 239000011653 vitamin D2 Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000010000 Agranulocytosis Diseases 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000013883 Blast injury Diseases 0.000 description 1
- 240000001829 Catharanthus roseus Species 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013082 Discomfort Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010014568 Empyema Diseases 0.000 description 1
- 206010051814 Eschar Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 206010018687 Granulocytopenia Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 239000009798 Shen-Fu Substances 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 210000000860 cochlear nerve Anatomy 0.000 description 1
- 238000011284 combination treatment Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 208000028659 discharge Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 231100000333 eschar Toxicity 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008862 fructus schizandrae, radix ginseng, radix ophiopogonis drug combination Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 239000008361 herbal raw material Substances 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 208000027753 pain disease Diseases 0.000 description 1
- 229940023462 paste product Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229960003600 silver sulfadiazine Drugs 0.000 description 1
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000011285 therapeutic regimen Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种用于临床护理烧伤的药物组合物及其制备方法,其组成原料的重量份为:含羞草25份、紫草12份、虎杖10份、白芷10份、栀子6份、黄连35份、丁香30份、金银花15份、黄芩30份、当归30份、没药12份、苍术6份、地榆10份、五倍子12份、珍珠10份、乌梅6份、炉甘石10份、三七2份、寒水石8份、防风5份、白背叶10份、白蔹6份、乳香8份、血竭10份。本申请的临床护理烧伤的药物组合物成本低廉,疗效显著,治疗后不留疤痕,具有广阔的应用前景。
Description
技术领域
本发明属于中药领域,更具体地,本发明涉及一种临床护理烧伤烫伤病人的药物组合物及其制备方法。
背景技术
烧伤、烫伤在人们日常生活中十分常见,烧伤是机体直接接触高温物体或受到强的热辐射所发生的变化,是由高温、化学物质或电引起的组织损伤。烧伤的程度由温度的高低、作用时间的长短而不同,局部的变化可分为四度:第一度:因血管麻痹而充血;第二度:形成充满血清的烧伤水疱;第三度:组织坏死;第四度:组织的炭化。烧伤时可见血液中的乳酸量增加,动静脉血的pH值降低,随着组织毛细血管功能障碍的加重,缺氧血症也严重。
中医关于烧伤有着深厚的理论基础,中医认为烧伤亦称火烧疮、汤泼火烧、汤火伤。轻浅者通常不影响内脏功能,仅在局部出现红晕,起疱,或腐烂;重者损害面积大而深,产生火盛伤阴,热毒炽甚,耗伤体内阴液。甚则热毒内攻,或气血两虚等全身症状,临床可见口渴,发热,便秘,小便不利甚或烦躁不宁,神昏谵语。治疗轻者只需外治,用地榆、大黄等量,冰片少许研末,香油调敷。重者宜辨证施治,清热解毒,凉营熄风,或固气养阴,回阳救逆,多选用黄连解毒汤、犀角地黄汤、羚羊钩藤汤或生脉散、参附汤等加味,若病程日久,耗伤气血者,则宜补气养血,可用八珍汤加味。外治方法包括清洗疮面,水泡处理,清除焦痂或植皮等项,亦可将上述药膏涂敷疮面,严重者应及时进行中西医抢救治疗。
西药治疗烧伤主要有:1.磺胺嘧啶银(CF-100),收敛作用强,可促使创面干燥,但是其缺点是可引起粒细胞减少;2.甲磺天脓适用于化脓性创面,对革兰氏阳性,革兰氏阴性细菌都有抑制作用,其缺点:1.局部应用有灼烧痛症感。2.部分病人有过敏。3.使结痂分离延迟,病程延长,抑制上皮细胞生长不利创面愈合。3.庆大霉素,广谱抗菌,对创面无刺激,无疼痛,护理方便,其缺点:长期大量用后可引起肾功能障碍,听神经损害,易产生耐药性。
目前,多数治疗烧伤烫伤的药物治疗效果并不十分理想,部分药物在治疗烧伤烫伤时需要的周期较长,或治疗后仍存在疤痕的现象,或每天需要的用药量次数多,给患者带来诸多不便,另外就是有的药物在治疗烧伤烫伤时,患者不能在室外走动,限制了患者的活动量,抑或在药物中加入过多的化学成分,对患者的身体造成潜在的危害。
发明内容
本申请的发明人结合祖传秘方根据前人经验及自己多年的医疗实践,通过对传统中药的研究,并结合辩证论证,多方收集众家之长,以中医外治为主,寻求最佳治疗方案,采用纯天然中草药原料,结合传统中医技术精心配制成本发明的临床护理烧伤的药物组合物,该中药组合物不仅对烧伤烫伤处治愈周期短,1度烧伤或烫伤3到5天可痊愈,2度烧伤或烫伤7-12天可痊愈,3度烧伤或烫伤15-25即可,患者只需要一天换1-2次药即可,为患者带来方便,另外,该组合物治愈率达100%。
为了实现上述目的本发明采用如下技术方案:
一种临床护理烧伤的药物组合物,其特征在于它是由下述重量配比的原料制作而成:
含羞草20-25份、紫草12-15份、虎杖10-25份、白芷8-12份、
栀子6-7份、黄连30-40份、丁香26-32份、金银花12-18份、
黄芩28-32份、当归26-32份、没药12-18份、苍术6-8份、
地榆8-12份、五倍子10-12份、珍珠10-12份、乌梅5-8份、
炉甘石10-12份、三七1-3份、寒水石8-12份、防风5-6份、
白背叶10-12份、白蔹4-6份、乳香8-12份、血竭4-8份。
所述的临床护理烧伤的药物组合物,其特征在于其组成原料的重量份优选为:
含羞草25份、紫草12份、虎杖10份、白芷10份、
栀子6份、黄连35份、丁香30份、金银花15份、
黄芩30份、当归30份、没药12份、苍术6份、
地榆10份、五倍子12份、珍珠10份、乌梅6份、
炉甘石10份、三七2份、寒水石8份、防风5份、
白背叶10份、白蔹6份、乳香8份、血竭10份。
方解:
1含羞草;性味:性微寒,味甘、涩;有小毒。功能主治:安神镇静,散瘀止痛,止血收敛。用于神经衰弱、跌打损伤、咯血、带状疱疹;
2、紫草:药性甘、咸、寒。归心、肝经;功效:清热凉血解毒透疹;
3、虎杖:药性微苦,微寒。归脾、胆、肺经;功效:利胆退黄,清热解毒,散瘀止痛,化痰止咳;
4、白芷:药性辛、温。归脾、胃、大肠经;功效:解毒散寒,祛风止痛,通鼻窍,燥湿止带,消肿排脓;
5、栀子:药性苦寒,归心、肺、三焦经;功效:泻火除烦,清热利湿,凉血解毒;
6、黄连:药性苦寒。归心、脾、胃、胆、大肠经;功效:清热燥湿、泻大解毒;
7、丁香:性辛,温;入胃、脾、肾经,降逆,抗真菌;
8、金银花:药性甘寒,归肺、心、胃经;功效:清热解毒,疏散风热;
9、黄芩:药性苦寒。归肺、胆脾、胃、大肠小肠经;功效:清热燥湿,泻火解毒,止血;
10、当归:药性甘、辛、温。归肝、心、脾经;功效:补血调经,活血止痛,润肠通便;
11、没药:性苦、平,散血去淤,消肿止痛,生肌,杀菌;
12、苍术:药性辛、苦、温,归脾、胃、肝经;功效:燥湿健脾,祛风散寒;
13、地榆:药性苦、酸、涩,微寒。归肝、大肠经;功效:凉血止血,解毒敛疮;
14、五倍子:药性酸、涩、寒。归肺、大肠、肾经;
15、珍珠:性味甘、咸、寒,能镇心安神,解毒生肌;
16、乌梅:药性酸,涩,平。归肝、脾、肺、大肠经;功效:敛肺止咳,涩肠止泻,安蛔止痛,生津止渴;
17、炉甘石:药性甘平,归肝、胃经;功效:解毒明目退翳,收湿止痒蔹疮;
18、三七:性甘微苦,温,无毒,止血,散淤,消肿止痛,抗病毒;
19、寒水石:药性辛、成、寒。归心、胃肾;功效:清热泻火;
20、防风:辛、甘,温。归膀胱、肝、脾经。解表祛风,胜湿,止痉;
21、白背叶:寒,无毒。清热,利湿,止痛,解毒,止血。治淋浊,胃痛,口疮,痔疮,溃疡,跌打损伤,蛇咬伤,外伤出血;
22、白蔹:性苦、辛、微寒。归心、胃经;功效:清热解毒,敛疮生肌,消痛散结;
23、乳香:性辛、苦、降逆、抗真菌;
24、血竭:药性甘、咸、平归肝经;功效:活血定痛,化瘀止血,敛疮生肌;
本发明的药物组合物其制备方法为:
按质量比例取用各种中药材粉碎至100-150目的细粉,混合放入广口玻璃瓶内,备用。
本发明的临床护理烧伤的药物组合物可以制备成膏状,方法是:
按质量比例取用各种中药材粉碎至100-150目的细粉,混合放入广口玻璃瓶内,备用,然后加入重量为原料组分重量4倍的香油,搅拌均匀即得膏状产品。
患者在使用本发明的药物时,烧伤或烫伤无论是否出现破皮,均不用纱布包裹,将伤口用消毒水清理后,涂敷本发明的组合物,一天换药1次即可;不破皮的采用本发明的药膏或药粉涂抹在患处,烫伤或烧伤的前两天,一天也可换药1-3次;
与现有技术相比,本发明提供的一种临床护理烧伤的药物组合物及其制备方法具有以下优点:
1、使用方法简单,不需要与其他抗菌素结合治愈周期短,见效快,且不留疤痕;
2、每天换药的次数少,给患者带来很多方便,患者在治疗过程中,可以在室内或室外自由活动;
3、1度、2度或3度烧伤或烫伤的治愈率均可达100%,即使是三度烧伤,半个月即可完全治愈;
4、制备方法简单,成本低,可以进行规模性生产
5、严重烧伤或烫伤后,不需要设置无菌室,不需要红外线照射或植皮,不易感染,在普通的环境即可治疗,没有无菌环境的要求,适用于各类烧伤或烫伤。
具体实施方式
实施例1:
一种临床护理烧伤的药物组合物,其组成原料的重量份为:
含羞草25份、紫草12份、虎杖10份、白芷10份、
栀子6份、黄连35份、丁香30份、金银花15份、
黄芩30份、当归30份、没药12份、苍术6份、
地榆10份、五倍子12份、珍珠10份、乌梅6份、
炉甘石10份、三七2份、寒水石8份、防风5份、
白背叶10份、白蔹6份、乳香8份、血竭10份。
按质量比例取用各种中药材粉碎至100-150目的细粉,混合放入广口玻璃瓶内,备用。
实施例2:
一种临床护理烧伤的药物组合物,其组成原料的重量份为:
含羞草25份、紫草12份、虎杖10份、白芷10份、
栀子6份、黄连35份、丁香30份、金银花15份、
黄芩30份、当归30份、没药12份、苍术6份、
地榆10份、五倍子12份、珍珠10份、乌梅6份、
炉甘石10份、三七2份、寒水石8份、防风5份、
白背叶10份、白蔹6份、乳香8份、血竭10份。
按质量比例取用各种中药材分别粉碎至100-150目的细粉,混合放入广口玻璃瓶内,然后取上述中药总量4倍的香油,添加搅拌均匀得膏状药物。
实施例3:
1.本组病人320例,其中住院病人158例占49.4%,门诊病人162例占50.6%。年龄最大78岁,最小10月。平均年玲36岁。烧伤常见原因:(1)开水烫伤,(2)火烧伤,(3)热气流冲击伤,(4)化学物质烧伤,如硫酸,石灰水,(5)排气管烫伤。
烧伤部位:四肢烧伤201例占63%;头面部烧伤87例占27%;躯干32例占10%。3.烧伤面积及深度:I度烧伤86例,最大面积占全身面积23.6%,;浅II度烧伤105例,最大烧伤面积37%,深II度烧伤93例,最大烧伤面积17%;III度烧伤36例,最大烧伤面积5%。
2.治疗方法
对于刚烧伤的新鲜创面,入院后给以用碘伏或碘络酮液消毒,并清除创面上的污物,有水泡低位剪破放出积液,保留泡皮。但蛋白冻形成给以泡皮及蛋白冻全部清除。游离或皱折的坏死腐皮予以清除,清除干净后再消毒一次。涂敷本发明得临床护理烧伤的药物组合物的粉末剂或膏剂,24小时换药一次,连续换药3次,每次换药时应给予创面清创。
3.治疗结果
本组320例,I度烧伤86例,5天内全部愈合。浅II度烧伤105例,深II度烧伤93例,7~15天愈合。III度烧伤36例,15~25天愈合。早期入院的II度-III度病人经清创包扎或暴露治疗,没有出现因炎性反应而影响愈合。晚期入院的II度-III度病人,因烧伤局部出现感染组织液化痂下或痂下积脓,虽经彻底清创,局部组织氧化,但仍出现炎性病变影响愈合。本组仅有2例III度烧伤的病人虽经清创周边缘皮肤爬生再生修复而自行愈合,但仍留有条状疤痕。临床追访1~3年173例占54%,没有其他不适。
实施例4
下述为采用本发明的药物组合物后的部分患者治疗情况
杨某 女 年龄31岁,小腿及大腿处被开水烫伤,烫伤处红肿,起泡,烧伤面积达10%,涂敷本发明组合物粉末制剂后,3天后痊愈,且烫伤处不留疤痕,患者在敷药的过程中,没有疼痛感,治愈率达100%;
刘某 男 年龄24岁,脚步被烧伤,属严重烧伤,烧伤面积达35%,涂敷本发明药物组合物膏状制剂后,12天后痊愈,治愈后不留疤痕;
王某 女 年龄60岁,手臂处被烧伤,烧伤面积达25%,出现破皮现象,涂覆本发明的组合物药粉后,7天痊愈,治愈后患处不留疤痕,治愈率达100%;
李某 男 年龄22岁,腿部烧伤严重,从其它医院转入治疗,患处腐烂,病情严重无法控制,患者疼痛不堪,伤口恶化感染,后采用本发明的组合物治疗7天后病情大大好转,25天后痊愈,愈后不留疤。
本发明采用的上述各中药互作配伍,能发挥其协同治病作用,所用中药原料各成分之间具有药效相互交织相互促进和协调效能,经临床验证,可用于不同程度的烧伤、烫伤,本申请人近十年的医疗实践中,治愈的病例数目众多,均取得良好的效果,而且成本低廉,减轻患者的负担。
本申请的临床护理烧伤的药物组合物成本低廉,疗效显著,治疗后不留疤痕,具有广阔的应用前景。
Claims (2)
1.一种临床护理烧伤的药物组合物,其特征在于,其组成原料的重量份为:
含羞草25份、紫草12份、虎杖10份、白芷10份、
栀子6份、黄连35份、丁香30份、金银花15份、
黄芩30份、当归30份、没药12份、苍术6份、
地榆10份、五倍子12份、珍珠10份、乌梅6份、
炉甘石10份、三七2份、寒水石8份、防风5份、
白背叶10份、白蔹6份、乳香8份、血竭10份。
2.权利要求1所述的临床护理烧伤的药物组合物在制备治疗烧伤烫伤药物中的用途。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011102578366A CN102357164B (zh) | 2011-09-02 | 2011-09-02 | 一种临床护理烧伤的药物组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011102578366A CN102357164B (zh) | 2011-09-02 | 2011-09-02 | 一种临床护理烧伤的药物组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102357164A CN102357164A (zh) | 2012-02-22 |
CN102357164B true CN102357164B (zh) | 2013-02-20 |
Family
ID=45582581
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011102578366A Expired - Fee Related CN102357164B (zh) | 2011-09-02 | 2011-09-02 | 一种临床护理烧伤的药物组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102357164B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104689016A (zh) * | 2015-02-12 | 2015-06-10 | 傅勇 | 一种治疗烧伤的外敷中药 |
CN104922308A (zh) * | 2015-07-12 | 2015-09-23 | 姚静 | 一种用于热烧伤护理的中药制剂及制备方法 |
CN105726699A (zh) * | 2016-03-21 | 2016-07-06 | 屠炳军 | 一种治疗烧烫伤药液及其制备方法 |
CN106138723A (zh) * | 2016-07-26 | 2016-11-23 | 合肥宝花堂健康咨询有限公司 | 一种外用中药膏 |
CN108420919A (zh) * | 2018-05-17 | 2018-08-21 | 安徽华康药业有限公司 | 一种用于治疗烧伤烫伤的中草药植物软膏及其制备方法 |
-
2011
- 2011-09-02 CN CN2011102578366A patent/CN102357164B/zh not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
中国中医烫伤药的研究概述;王茂先;《科技资讯》;20101231(第02期);第231-233页 * |
王茂先.中国中医烫伤药的研究概述.《科技资讯》.2010,(第02期),第231-233页. |
Also Published As
Publication number | Publication date |
---|---|
CN102357164A (zh) | 2012-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102327478B (zh) | 一种治疗烧烫伤的药物组合物及其制备方法 | |
CN102319350B (zh) | 一种用于治疗烧、烫伤的外用烫伤油药物组合物 | |
CN102357164B (zh) | 一种临床护理烧伤的药物组合物及其制备方法 | |
CN104352587A (zh) | 一种治疗鼻炎的软膏 | |
CN102688360B (zh) | 一种治疗烧烫伤的皮肤外用药 | |
CN101301406B (zh) | 治疗骨质增生、椎间盘突出以及颈椎炎、风湿关节炎的外敷剂 | |
CN101143171B (zh) | 一种中药药物、其制备方法及其应用 | |
CN102309723A (zh) | 一种治疗关节疼痛的中药组合物及其药膏的制备方法 | |
CN104491107A (zh) | 治疗烧伤的中药制剂及其制备方法 | |
CN104984148A (zh) | 一种临床用中药伤口护理组合物 | |
CN103908600A (zh) | 治疗类风湿性关节炎湿热痹阻证的外用药物、制备方法及给药方式 | |
CN108498617A (zh) | 风湿痛中药组合物及其制备方法和应用、足浴包及其制备方法和药物制剂 | |
CN103341151B (zh) | 用于治疗慢性支气管炎的中药 | |
CN102552560B (zh) | 一种有效治疗手足口病的复方组合药物 | |
CN105535331A (zh) | 一种治疗宫颈糜烂的外用药膏及其制备方法 | |
CN101496835A (zh) | 一种治疗儿童感冒及退热的药物及其制备方法 | |
CN104997945A (zh) | 一种治疗膀胱炎的中药 | |
CN103599377A (zh) | 治疗烧伤的中药 | |
CN103830425A (zh) | 一种治疗血虚型皮肤瘙痒的中药 | |
CN107929492A (zh) | 一种治疗脓肿的壮医外用制剂及其制备方法 | |
CN108498649B (zh) | 一种蝎芪药膏 | |
CN105326943A (zh) | 一种治痔疮的纯中药 | |
CN105311370A (zh) | 一种用于电烧伤的制剂及其制备工艺 | |
CN104940635A (zh) | 一种烫烧伤外用中药组合物 | |
CN104127741A (zh) | 一种治疗糖尿病的中药组方 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130220 Termination date: 20130902 |